Related references
Note: Only part of the references are listed.
Article
Oncology
Yang Ye et al.
Summary: The study investigated the effect of 3,3'-diindolylmethane (DIM) on ferroptosis against gastric cancer and found that DIM could induce ferroptosis in BGC-823 gastric cancer cells by upregulating lipid-ROS levels and decreasing GSH generation. DIM also reduced the protein levels of SLC7A11 and GPX4 while increasing BAP1 and IP3R levels. The findings suggest that DIM exerts anti-cancer effects through the BAP1-IP3R axis and has therapeutic potential in gastric cancer.
Article
Biochemistry & Molecular Biology
Guoquan Huang et al.
Summary: This study found that BDNF-AS is highly expressed in gastric cancer and peritoneal metastasis tissues, and its overexpression is associated with gastric cancer progression and poor prognosis. BDNF-AS overexpression protects gastric cancer cells from ferroptosis and promotes the progression of gastric cancer and peritoneal metastasis. Mechanistically, BDNF-AS regulates the transcription of FBXW7 by recruiting WDR5, thus affecting the ubiquitination of VDAC3.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES
(2022)
Article
Biochemistry & Molecular Biology
Man Jiang et al.
JOURNAL OF BIOCHEMISTRY
(2022)
Article
Cell Biology
Ruoxi Xiao et al.
Summary: This study identified a ferroptosis-related gene prognostic signature for stomach adenocarcinoma (STAD) and validated its reliability in predicting patient outcomes. The study also found that the signature has relevance to immune characteristics and may improve the efficacy of personalized immunotherapy.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
(2022)
Review
Biochemistry & Molecular Biology
Chen Zhang et al.
Summary: Ferroptosis, an iron-dependent form of cell death, plays a crucial role in tumor suppression and has the potential to reverse cancer therapy resistance.
Article
Oncology
Gongjun Wang et al.
Summary: This study identified differentially expressed lncRNAs associated with overall survival and progression-free survival in stomach adenocarcinoma (STAD). Two signatures based on these lncRNAs were established to predict the prognosis of STAD. Furthermore, the study confirmed the role of lncRNA LASTR in gastric cancer and explored its relationship with ferroptosis. These findings provide potential targets for tumor treatment and contribute to personalized medicine.
MOLECULAR MEDICINE REPORTS
(2022)
Article
Cell Biology
Deng Guan et al.
Summary: Research revealed that DpdtbA resisted TGF-beta 1-induced EMT through ferritinophagy-mediated ROS production, promoting EMT inhibition. Additionally, activation of Nrf2 played a role in regulating the cellular redox environment changes.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
(2022)
Article
Oncology
Liyi Zhang et al.
Summary: This study found that Ophiopogonin B (OP-B) suppresses gastric cancer cell viability and induces ferroptosis by blocking the GPX4/xCT system.
Article
Multidisciplinary Sciences
Jie Wang et al.
Summary: This study finds that EBV-miR-BART11 and EBV-miR-BART17-3p upregulate the expression of PD-L1 in EBV-associated cancers and elucidates the underlying regulatory mechanism, promoting tumor immune escape and providing potential targets for EBV-related tumor immunotherapy.
NATURE COMMUNICATIONS
(2022)
Article
Genetics & Heredity
Donlin Lai et al.
Summary: This study investigates the combined effects of ferroptosis and lncRNAs on the prognosis and therapy of stomach cancer. A prognostic model consisting of 10 ferroptosis-related lncRNAs was constructed and validated. The model had guiding significance for prognosis and personalized therapy, helping to identify stomach cancer patients who might benefit from immunotherapy and guiding the selection of personalized chemotherapeutic drugs. The study also revealed differences in immune response and sensitivity to certain chemotherapy drugs among different risk groups.
FRONTIERS IN GENETICS
(2022)
Article
Oncology
Siyuan Song et al.
Summary: This study identified the mechanism by which Yiqi Huayu Decoction (YQHY) induces ferroptosis in gastric cancer (GC) using network pharmacology and experimental validation. The results showed that YQHY can induce ferroptosis in GC by affecting the JAK2-STAT3 pathway and the expression of ACSL4. This induction of ferroptosis may be one of the possible mechanisms of YQHY's anti-recurrence and metastasis of GC.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Jinping Zhang et al.
Summary: The compound 6-TG was identified as a potential ferroptosis inducer in gastric cancer cells, showing anti-tumor activity by triggering iron-mediated ferroptosis.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2022)
Article
Biochemistry & Molecular Biology
Mingzhe Ma et al.
Summary: This study identified a link between methionine cycle activity and susceptibility to ferroptosis, and discovered the role of MAT2A in ferroptosis resistance.
FREE RADICAL BIOLOGY AND MEDICINE
(2022)
Article
Genetics & Heredity
Shuqiong Zhang et al.
Summary: We identified a three-ferroptosis-related-lncRNA signature (AP000695.2, AL365181.3, and LINC01615) that can predict the prognosis of STAD patients. The GSEA indicated that these three ferroptosis-related lncRNAs might be related to the extracellular matrix and cellular activities.
FRONTIERS IN GENETICS
(2022)
Review
Oncology
Yue Zhang et al.
Summary: This review provides a detailed overview of the classification, characteristics, biogenesis, functions, and latest advances in cancer research of circular RNAs (circRNAs). The unique features of circRNAs, such as their high abundance, strong specificity, and good stability, have been identified, and their various functions and mechanisms in biological events, including cancer occurrence and development, have been extensively studied. The development of circRNAs as biomarkers in cancer diagnosis and treatment also opens up new avenues for circRNA research.
FRONTIERS IN ONCOLOGY
(2022)
Article
Biochemistry & Molecular Biology
Shunv Cai et al.
Summary: This study found that silencing SIRT6 can overcome sorafenib resistance in gastric cancer by promoting ferroptosis. Mechanistically, SIRT6 inhibition leads to inactivation of the Keap1/Nrf2 pathway and downregulation of GPX4, while over-expression of GPX4 or activation of Keap1/Nrf2 can reverse the effects. Targeting the SIRT6/Keap1/Nrf2/GPX 4 pathway may be a potential strategy for overcoming sorafenib resistance in gastric cancer.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
(2021)
Article
Oncology
Jianming Wei et al.
Summary: In this study, a prognostic ferroptosis-related lncRNA signature was constructed for gastric cancer, with the low-risk group showing significantly better prognosis than the high-risk group. The risk score was identified as an independent prognostic factor. This risk model provides a novel method for predicting prognosis in gastric cancer patients.
Article
Biotechnology & Applied Microbiology
Shi-jin Liu et al.
Summary: The study reveals the important role of ferroptosis-related genes in the pathogenesis of gastric cancer. Patients with high FRGScore have worse prognosis, and the constructed prognostic model shows superior accuracy. FRG RiskScore can act as an independent biomarker for the prognosis of GC patients.
Article
Oncology
Liying Zhao et al.
Summary: In summary, apatinib induces lipid peroxidation through GPX4 mediated by SREBP-1a, leading to the ferroptosis of gastric cancer cells, including multi-drug resistant ones.
Article
Cell Biology
Yanfei Shao et al.
Summary: The study constructed a prognostic signature of 10 ferroptosis-related genes, which effectively predict the survival rate and immunotherapy response of gastric cancer patients. By screening differentially expressed genes and dividing patients into high-risk and low-risk groups based on risk scores, it was found that patients in the low-risk group had better survival possibilities.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
(2021)
Article
Cell Biology
Haiyang Zhang et al.
Summary: Cancer stem cells are influenced by ferroptosis, a form of cell death involving iron ions and regulated by intracellular signals. The role of ferroptosis in tumor stem cells is crucial for understanding mechanisms of recurrence and drug resistance in cancers.
CELL DEATH & DISEASE
(2021)
Review
Cell Biology
Na Jiang et al.
Summary: Long non-coding RNAs (lncRNAs) are transcripts longer than 200 nucleotides that regulate gene expressions at various levels. Studies have shown that lncRNAs are closely related to programmed cell death (PCD) and play important roles in various cancers.
CELL DEATH DISCOVERY
(2021)
Article
Biotechnology & Applied Microbiology
Feng Wang et al.
Summary: A novel FRG signature was established in this study to predict GC prognosis and reflect the status of the tumor immune microenvironment.
BIOMED RESEARCH INTERNATIONAL
(2021)
Review
Biochemical Research Methods
Huiwen Yan et al.
Summary: The majority of the human genome is transcribed into non-coding RNAs (ncRNAs) that play crucial roles in regulating cancer initiation and progression. This review focuses on recent studies of the function, regulatory mechanisms, and therapeutic potential of ncRNAs such as microRNA (miRNA), long ncRNA (lncRNA), circular RNA (circRNA), and PIWI interacting RNA (piRNA) in various types of cancers.
Article
Oncology
Xinming Chen et al.
Summary: The study identified a carcinogenic risk signature using ferroptosis-related ncRNAs for predicting prognoses of gastric adenocarcinoma patients. Patients in the high-risk group had higher immune cell recruitment, and the overall effect of anti-immune checkpoint immunotherapy was not as effective as in the low-risk group. High- and low-risk groups were enriched in tumor- and immune-related pathways, respectively.
FRONTIERS IN ONCOLOGY
(2021)
Article
Oncology
Yi-Ping Liu et al.
Summary: The study revealed that propofol inhibits proliferation, induces apoptosis, suppresses invasion and migration of gastric cancer cells. It induces ferroptosis by regulating the miR-125b-5p/STAT3 axis, suggesting its potential as a therapeutic candidate for gastric cancer.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
(2021)
Article
Cell Biology
Shilang Xiao et al.
Summary: This study revealed that by varying the activation degrees of ferroptosis, tumor cells and their surrounding microenvironment could be shaped. Establishing ferroptosis-related subtypes would guide in predicting the biological features of individual tumors and selecting appropriate treatment protocols for patients.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Cell Biology
Fuwen Yao et al.
Summary: The study showed that high expression of hub FRGs in gastric cancer is associated with poor overall survival in patients, with CD4(+) T cells being the major infiltrated cells in the tumor microenvironment. Furthermore, the hub FRGs are significantly correlated with activated CD4(+) T cell infiltration, suggesting their potential role in mediating CD4(+) T cell activation through various signaling pathways.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Cell Biology
Shilang Xiao et al.
Summary: This study systematically evaluated the role of ferroptosis-related lncRNAs in GC, and found that risk stratification could reflect the biological characteristics and treatment response of GC patients. The ferroptosis-related lncRNA signature could serve as a reliable biomarker for predicting the prognosis and therapeutic response of GC patients.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2021)
Article
Nutrition & Dietetics
Junfu Ma et al.
Summary: The study identified two distinct ferroptosis subtypes in gastric cancer and revealed marked differences in sex hormone receptors and immune cell infiltration. Gender differences may play a critical role in the application of ferroptosis-related strategies in gastric cancer treatment. Patients with low-ferroptosis scores showed increased immune response, better response to immunotherapy, and lower estimated IC50 in several chemotherapy drugs.
FRONTIERS IN NUTRITION
(2021)
Article
Medicine, General & Internal
Xiaotao Jiang et al.
Summary: Our study established two ferroptosis subtypes in gastric cancers, with C2 showing higher FSS and lower FPI compared to C1. These subtypes were associated with different TME characteristics, with C2 displaying an immune-excluded phenotype and C1 linked to an immune-inflamed phenotype. The assessment of ferroptosis patterns and levels may provide valuable insights for the development of targeted immunotherapeutic strategies for GC patients.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(2021)
Article
Pharmacology & Pharmacy
Ying Liu et al.
Summary: The new JDA derivative a2 was found to inhibit the growth of gastric cancer cells and induce ferroptosis. Through the autophagy pathway, a2 caused ferrous iron accumulation, and prevention of this process alleviated a2-induced elevation of ferrous iron and cell growth inhibition, demonstrating stronger anti-cancer activity in gastric cancer xenograft models compared to 5-fluorouracil.
ACTA PHARMACEUTICA SINICA B
(2021)
Article
Biochemistry & Molecular Biology
Dazhi Fu et al.
Summary: The study revealed that upregulation of ATF3 in gastric carcinoma cells can sensitize them to cisplatin chemotherapy by inducing ferroptosis and inhibiting Nrf2/Keap1/xCT signaling pathway. This suggests a potential therapeutic approach for overcoming chemoresistance in advanced gastric carcinoma.
CELLULAR & MOLECULAR BIOLOGY LETTERS
(2021)
Article
Biotechnology & Applied Microbiology
WenZheng Chen et al.
Summary: The study identified 20 ferroptosis-related lncRNAs and constructed a prognostic signature to classify gastric cancer patients into high-risk and low-risk groups. The signature was an independent prognostic indicator of survival and associated with immune cell infiltration, potentially aiding in personalized prognoses and treatments for gastric cancer patients.
Article
Biochemistry & Molecular Biology
Jing Wang et al.
Summary: In this study, it was found that CPEB1 promotes erastin-induced ferroptosis by inhibiting twist1. Overexpression of CPEB1 makes GC cells more sensitive to erastin, while silencing CPEB1 makes cells more resistant. This demonstrates the importance of CPEB1 in regulating ferroptosis in gastric cancer.
Review
Biochemistry & Molecular Biology
Xiao-Huan Tang et al.
Summary: Exosomes, a subpopulation of the tumour microenvironment (TME), are crucial for intercellular communication and are enriched with noncoding RNAs that play important roles in the tumorigenesis, progression, and drug resistance of gastric cancer (GC). Regulating exosomal ncRNAs levels could potentially serve as therapeutic targets for GC treatment.
Article
Genetics & Heredity
Junyu Huo et al.
Summary: The risk score established using hypoxia- and ferroptosis-related genes showed good performance in predicting overall survival and relapse-free survival in gastric cancer patients. This eight-gene signature may improve the prognostic risk classification of gastric cancer.
Article
Cell & Tissue Engineering
Haiwei Ni et al.
Summary: The study revealed that miR-375 can reduce the stemness of gastric cancer cells by targeting SLC7A11 and triggering ferroptosis. The miR-375/SLC7A11 regulatory axis may serve as a potential therapeutic target to attenuate the stemness of gastric cancer cells.
STEM CELL RESEARCH & THERAPY
(2021)
Article
Pharmacology & Pharmacy
Shun-Hong Mao et al.
Summary: Levobupivacaine induces ferroptosis of gastric cancer cells to repress cell growth by regulating the miR-489-3p/SLC7A11 axis.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Genetics & Heredity
Junhong Ye et al.
Summary: Significant progress has been made in the field of non-coding RNAs, with a focus on miRNAs, lncRNAs, circRNAs, and their roles in diseases like cancer. In gastric cancer research, the complex ceRNA crosstalk mechanism has provided new insights into the disease and potential therapeutic targets.
Article
Genetics & Heredity
Jiahui Pan et al.
Summary: By analyzing ferroptosis-related lncRNAs, a gastric cancer prognostic signature model including 17 lncRNAs was constructed by the research team, improving survival prediction for gastric cancer patients. The model showed good predictive ability in prognosis evaluation.
FRONTIERS IN GENETICS
(2021)
Article
Oncology
Xiaoying Sun et al.
Article
Biochemistry & Molecular Biology
Haiyang Zhang et al.
Article
Oncology
Chang Li et al.
CANCER CELL INTERNATIONAL
(2020)
Review
Biochemistry & Molecular Biology
Ling Wei et al.
Article
Biochemistry & Molecular Biology
Zhenhua Guan et al.
BIOSCIENCE REPORTS
(2020)
Review
Oncology
Yi Li et al.
Article
Biochemistry & Molecular Biology
Yaqing Li et al.
Article
Multidisciplinary Sciences
Ji-Yoon Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2020)
Article
Medicine, Research & Experimental
Ying Niu et al.
Article
Multidisciplinary Sciences
Ahmed Gomaa et al.
SCIENTIFIC REPORTS
(2019)
Review
Oncology
Ya-Jun Luo et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
(2019)
